Advanced search
Publication Cover
Acta Oncologica Volume 48, 2009 - Issue 1
Journal homepage
3,032
Views
101
CrossRef citations to date
0
Altmetric
Original Article

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study

Christina M. Schilder Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, AmsterdamCorrespondence[email protected]
,
Petronella C. Eggens Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam
,
Caroline Seynaeve Department of Medical Oncology, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam
,
Sabine C. Linn Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam
,
Willem Boogerd Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam; Department of Neurology, Slotervaart Medical Center, Amsterdam
,
Chad M. Gundy Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam
,
Louk V. Beex Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
,
Frits S. Van Dam Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam
&
Sanne B. Schagen Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam
 show all
Pages 76-85 | Received 14 Feb 2008, Published online: 08 Jul 2009

Citations (101)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

R. Reuben, L. Karkaby, C. McNamee, N. A. Phillips & G. Einstein. (2021) Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline?. Climacteric 24:4, pages 321-332.
Read now
Barbara Fischer. (2019) Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study. Neurocase 25:3-4, pages 138-144.
Read now
Tulay Kus, Gokmen Aktas, Hatice Ekici & Gulcin Elboga. (2017) Comparison of distress in breast cancer survivors treated with different adjuvant endocrine therapies: a single-centre cross-sectional study. Psychiatry and Clinical Psychopharmacology 27:3, pages 271-277.
Read now
Carla Calhoun, Kathy J. Helzlsouer & Lisa Gallicchio. (2015) Racial Differences in Depressive Symptoms and Self-Rated Health Among Breast Cancer Survivors on Aromatase Inhibitor Therapy. Journal of Psychosocial Oncology 33:3, pages 263-277.
Read now
Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles & Gary R. Morrow. (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry 26:1, pages 102-113.
Read now
GA Walker, M Xenophontos, LC Chen & KL Cheung. (2013) Long-term efficacy and safety of exemestane in the treatment of breast cancer. Patient Preference and Adherence 7, pages 245-258.
Read now
Caroline H. Walker, Barbara A. Drew, James W. Antoon, Alan V. Kalueff & Barbara S. Beckman. (2012) Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives. Cancer Investigation 30:2, pages 135-148.
Read now
Michael Batalo, Govardhanan Nagaiah & Jame Abraham. (2011) Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Review of Anticancer Therapy 11:8, pages 1277-1282.
Read now
Anneleen Lintermans, Patrick Neven & Robert Paridaens. (2011) Drug safety evaluation of exemestane. Expert Opinion on Drug Safety 10:3, pages 473-487.
Read now
Catherine M Kelly & Aman U Buzdar. (2010) Anastrozole. Expert Opinion on Drug Safety 9:6, pages 995-1003.
Read now

Articles from other publishers (91)

Feng Jing, Zheng Zhu, Jiajia Qiu, Lichen Tang, Lei Xu, Weijie Xing & Yan Hu. (2023) Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients: A network analysis. Frontiers in Oncology 13.
Crossref
Philippe R Lee Meeuw Kjoe, Jacobien M Kieffer, Brent J Small, Willem Boogerd, Christina M Schilder, Elsken van der Wall, Elma Meershoek-Klein Kranenbarg, Cornelis J H van de Velde & Sanne B Schagen. (2023) Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer. JNCI Cancer Spectrum 7:2.
Crossref
Javier García-Sánchez, Mayra Alejandra Mafla-España, María Dolores Torregrosa & Omar Cauli. (2022) Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study. The Breast 66, pages 310-316.
Crossref
Oveis Hosseinzadeh Sahafi, Ameneh Rezayof, Zahra Ghasemzadeh, Sakineh Alijanpour & Sepehrdad Rahimian. (2022) Ameliorating effect of fluoxetine on tamoxifen-induced memory loss: The role of corticolimbic NMDA receptors and CREB/BDNF/cFos signaling pathways in rats. Brain Research 1794, pages 148058.
Crossref
Giovana R. Onzi, Nathalia D’Agustini, Solange C. Garcia, Silvia S. Guterres, Paula R. Pohlmann, Daniela D. Rosa & Adriana R. Pohlmann. (2022) Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions. Drug Safety 45:6, pages 601-621.
Crossref
Ichrak Ben Abdallah, Haifa Rachdi, Nesrine Mejri, Yosra Berrazega, Soumaya Laabidi & Hamouda Boussen. (2022) Cognitive complaints during breast cancer endocrine therapy: aromatase inhibitors versus tamoxifen. BMJ Supportive & Palliative Care, pages bmjspcare-2021-003377.
Crossref
Trupti Trivedi & Theresa A. Guise. (2022) Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition. Bone 154, pages 116245.
Crossref
Amanda D. Hutchinson, Elise Thompson, Nicole Loft, Ian Lewis, Carlene Wilson & Agnes S. M. Yong. (2021) Cognitive late effects following allogeneic stem cell transplantation in haematological cancer patients. European Journal of Cancer Care 30:5.
Crossref
Sarah Eide & Zhong-Ping Feng. (2020) Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis. European Journal of Pharmacology 881, pages 173078.
Crossref
Gabriella Martino, Antonino Catalano, Rita Maria Agostino, Federica Bellone, Nunziata Morabito, Carmen Giulia Lasco, Carmelo Mario Vicario, Peter Schwarz & Ulla Feldt-Rasmussen. (2020) Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer. PLOS ONE 15:3, pages e0230681.
Crossref
Fulvia Di Iulio, Luca Cravello, Jacob Shofany, Stefano Paolucci, Carlo Caltagirone & Giovanni Morone. (2019) Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options. Neurological Sciences 40:9, pages 1759-1774.
Crossref
M. L. Gregorowitsch, A. Ghedri, D. A. Young-Afat, R. Bijlsma, I. O. Baas, C. van Schaik-van de Mheen, M. J. Agterof, E. Göker, D. ten Bokkel Huinink, H. J. G. D. van den Bongard & H. M. Verkooijen. (2019) The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Research and Treatment 175:2, pages 429-441.
Crossref
Kajal Gokal, Fehmidah Munir, Samreen Ahmed, Kiran Kancherla & Deborah Wallis. (2018) Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial. PLOS ONE 13:11, pages e0206874.
Crossref
Jeanne S. MandelblattBrent J. SmallGheorghe LutaArti HurriaHeather JimBrenna C. McDonaldDeena GrahamXingtao ZhouJonathan ClappWanting ZhaiElizabeth BreenJudith E. CarrollNeelima DenduluriAsma DilawariMartine ExtermannClaudine IsaacsPaul B. JacobsenLindsay C. KobayashiKelly Holohan NudelmanJames RootRobert A. SternDanielle TometichRaymond TurnerJohn W. VanMeterAndrew J. SaykinTim Ahles. (2018) Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Journal of Clinical Oncology 36:32, pages 3211-3222.
Crossref
Cheryl S. Rosenfeld, Dusti A. Shay & Victoria J. Vieira-Potter. (2018) Cognitive Effects of Aromatase and Possible Role in Memory Disorders. Frontiers in Endocrinology 9.
Crossref
Inge M Krul, Annemieke W J Opstal-van Winden, Josée M Zijlstra, Yolande Appelman, Sanne B Schagen, Lilian J Meijboom, Erik Serné, Cornelis B Lambalk, Paul Lips, Eline van Dulmen-den Broeder, Michael Hauptmann, Laurien A Daniëls, Berthe M P Aleman & Flora E van Leeuwen. (2018) Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA). BMJ Open 8:9, pages e018120.
Crossref
Victoria J. Bray, Haryana M. Dhillon & Janette L. Vardy. (2018) Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship 12:4, pages 537-559.
Crossref
Olivier Mir, Alexandre Salvador, Sarah Dauchy, Stanislas Ropert, Cédric Lemogne & Raphaël Gaillard. (2017) Everolimus induced mood changes in breast cancer patients: a case-control study. Investigational New Drugs 36:3, pages 503-508.
Crossref
Catherine Bender, John Merriman, Susan Sereika, Amanda Gentry, Frances Casillo, Theresa Koleck, Margaret Rosenzweig, Adam Brufsky, Priscilla McAuliffe, Yehui Zhu & Yvette Conley. (2018) Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer. Oncology Nursing Forum 45:3, pages 308-326.
Crossref
E. A. Underwood, P. A. Rochon, R. Moineddin, P. E. Lee, W. Wu, K. I. Pritchard & M. C. Tierney. (2017) Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Research and Treatment 168:2, pages 299-310.
Crossref
Lise Paquet, Shailendra Verma, Barbara Collins, Anne Chinneck, Marc Bedard & Xinni Song. (2017) Testing a novel account of the dissociation between self‐reported memory problems and memory performance in chemotherapy‐treated breast cancer survivors. Psycho-Oncology 27:1, pages 171-177.
Crossref
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian & Jill B. Rich. (2017) Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neuroscience & Biobehavioral Reviews 83, pages 417-428.
Crossref
Jennifer N. Vega, Julie Dumas & Paul A. Newhouse. (2017) Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults. The American Journal of Geriatric Psychiatry 25:12, pages 1415-1426.
Crossref
Tracy D. Vannorsdall. (2017) Cognitive Changes Related to Cancer Therapy. Medical Clinics of North America 101:6, pages 1115-1134.
Crossref
Jeffrey D. Blaustein. (2017) Treatments for Breast Cancer That Affect Cognitive Function in Postmenopausal Women. Policy Insights from the Behavioral and Brain Sciences 4:2, pages 170-177.
Crossref
Samira S. Valvassori, Cenita P. Borges, Roger B. Varela, Daniela V. Bavaresco, Guilherme Bianchini, Edemilson Mariot, Camila O. Arent, Wilson R. Resende, Josiane Budni & João Quevedo. (2017) The different effects of lithium and tamoxifen on memory formation and the levels of neurotrophic factors in the brain of male and female rats. Brain Research Bulletin 134, pages 228-235.
Crossref
Xingui Chen, Xiaoxuan He, Longxiang Tao, Jingjing Li, Jiaonan Wu, Chunyan Zhu, Fengqiong Yu, Lei Zhang, Jingjie Zhang, Bensheng Qiu, Yongqiang Yu & Kai Wang. (2017) The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen. International Journal of Neuropsychopharmacology 20:5, pages 374-382.
Crossref
Xingui Chen, Jingjing Li, Jingjie Zhang, Xiaoxuan He, Chunyan Zhu, Lei Zhang, Xinglong Hu & Kai Wang. (2017) Impairment of the executive attention network in premenopausal women with hormone receptor-positive breast cancer treated with tamoxifen. Psychoneuroendocrinology 75, pages 116-123.
Crossref
Sepideh Mansouri, Azin Teymourzadeh, Leila Farahmand & Keivan Majidzadeh-A. 2017. Cancer Genetics and Psychotherapy. Cancer Genetics and Psychotherapy 825 850 .
Ozturk Ates, Cem Soylu, Taner Babacan, Furkan Sarici, Neyran Kertmen, Deborah Allen, Ali Riza Sever & Kadri Altundag. (2016) Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors. SpringerPlus 5:1.
Crossref
Cuicui Li, Chenglin Zhou & Rena Li. (2015) Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?. Molecular Neurobiology 53:6, pages 4238-4246.
Crossref
Philip E. Lee, Mary C. Tierney, Wei Wu, Kathleen I. Pritchard & Paula A. Rochon. (2016) Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Research and Treatment 158:3, pages 407-420.
Crossref
Armin Shahrokni, Abraham J. Wu, Jeanne Carter & Stuart M. Lichtman. (2016) Long-term Toxicity of Cancer Treatment in Older Patients. Clinics in Geriatric Medicine 32:1, pages 63-80.
Crossref
Ioannis Bakoyiannis, Eleousa-Alexandra Tsigka, Despina Perrea & Vasilios Pergialiotis. (2015) The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review. Clinical Drug Investigation 36:2, pages 109-118.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 682 701 .
Alexandra McCarthy, Tina Skinner, Michael Fenech & Shelley Keating. 2016. Cancer and Chronic Conditions. Cancer and Chronic Conditions 203 239 .
Helena Harder & Valerie Jenkins. 2016. Breast Cancer Survivorship. Breast Cancer Survivorship 235 247 .
Kajal Gokal, Fehmidah Munir, Deborah Wallis, Samreen Ahmed, Ion Boiangiu & Kiran Kancherla. (2015) Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol. BMC Public Health 15:1.
Crossref
Natasha D. Buchanan, Sabitha Dasari, Juan L. Rodriguez, Judith Lee Smith, M. Elizabeth Hodgson, Clarice R. Weinberg & Dale P. Sandler. (2015) Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors. American Journal of Preventive Medicine 49:6, pages S498-S508.
Crossref
Clémentine Lopez, Cécile Charles, Pascal Rouby, Diane Boinon, Sophie Laurent, Annie Rey, Marc Spielmann & Sarah Dauchy. (2015) Relations between arthralgia and fear of recurrence: results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy. Supportive Care in Cancer 23:12, pages 3581-3588.
Crossref
Paul Newhouse & Julie Dumas. (2015) Estrogen–cholinergic interactions: Implications for cognitive aging. Hormones and Behavior 74, pages 173-185.
Crossref
Chun-Hung Chang, Shaw-Ji Chen & Chieh-Yu Liu. (2015) Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. Journal of Affective Disorders 182, pages 44-49.
Crossref
Catherine M. Bender, John D. Merriman, Amanda L. Gentry, Gretchen M. Ahrendt, Sarah L. Berga, Adam M. Brufsky, Frances E. Casillo, Meredith M. Dailey, Kirk I. Erickson, Frances M. Kratofil, Priscilla F. McAuliffe, Margaret Q. Rosenzweig, Christopher M. Ryan & Susan M. Sereika. (2015) Patterns of change in cognitive function with anastrozole therapy. Cancer 121:15, pages 2627-2636.
Crossref
Myrle M. Stouten-Kemperman, Michiel B. de Ruiter, Vincent Koppelmans, Willem Boogerd, Liesbeth Reneman & Sanne B. Schagen. (2014) Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior 9:2, pages 275-284.
Crossref
James C. Root, Elizabeth Ryan, Gregory Barnett, Charissa Andreotti, Kemi Bolutayo & Tim Ahles. (2015) Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints. Psycho-Oncology 24:5, pages 548-555.
Crossref
Naomi Seliktar, Carolee Polek, Ari Brooks & Thomas Hardie. (2015) Cognition in breast cancer survivors: hormones versus depression. Psycho-Oncology 24:4, pages 402-407.
Crossref
Miyuki Ono, James M. Ogilvie, Jennifer S. Wilson, Heather J. Green, Suzanne K. Chambers, Tamara Ownsworth & David H. K. Shum. (2015) A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer. Frontiers in Oncology 5.
Crossref
Stacy A. Eisenberg, Keiko Kurita, Megan Taylor‐Ford, David B. Agus, Mitchell E. Gross & Beth E. Meyerowitz. (2014) Intolerance of uncertainty, cognitive complaints, and cancer‐related distress in prostate cancer survivors. Psycho-Oncology 24:2, pages 228-235.
Crossref
Myrle M. Stouten-Kemperman, Michiel B. de Ruiter, Willem Boogerd, Dick J. Veltman, Liesbeth Reneman & Sanne B. Schagen. (2014) Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors. Journal of the International Neuropsychological Society 21:1, pages 50-61.
Crossref
Patricia A. GanzLaura PetersenSteven A. CastellonJulienne E. BowerDaniel H.S. SilvermanSteven W. ColeMichael R. IrwinThomas R. Belin. (2014) Cognitive Function After the Initiation of Adjuvant Endocrine Therapy in Early-Stage Breast Cancer: An Observational Cohort Study. Journal of Clinical Oncology 32:31, pages 3559-3567.
Crossref
Theresa A. Koleck, Catherine M. Bender, Susan M. Sereika, Gretchen Ahrendt, Rachel C. Jankowitz, Kandace P. McGuire, Christopher M. Ryan & Yvette P. Conley. (2014) Apolipoprotein E Genotype and Cognitive Function in Postmenopausal Women With Early-Stage Breast Cancer. Oncology Nursing Forum 41:6, pages E313-E325.
Crossref
Kelly N. H. Nudelman, Shannon L. Risacher, John D. West, Brenna C. McDonald, Sujuan Gao & Andrew J. Saykin. (2014) Association of cancer history with Alzheimer's disease onset and structural brain changes. Frontiers in Physiology 5.
Crossref
Jeanne S. MandelblattPaul B. JacobsenTim Ahles. (2014) Cognitive Effects of Cancer Systemic Therapy: Implications for the Care of Older Patients and Survivors. Journal of Clinical Oncology 32:24, pages 2617-2626.
Crossref
Xingui Chen, Jingjing Li, Juluo Chen, Dandan Li, Rong Ye, Jingjie Zhang, Chunyan Zhu, Yanghua Tian & Kai Wang. (2014) Decision-making impairments in breast cancer patients treated with tamoxifen. Hormones and Behavior 66:2, pages 449-456.
Crossref
Marie Lange, Olivier Rigal, Bénédicte Clarisse, Bénédicte Giffard, Emmanuel Sevin, Marie Barillet, Francis Eustache & Florence Joly. (2014) Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists. Cancer Treatment Reviews 40:6, pages 810-817.
Crossref
Kelly N. H. Nudelman, Yang Wang, Brenna C. McDonald, Susan K. Conroy, Dori J. Smith, John D. West, Darren P. O'Neill, Bryan P. Schneider & Andrew J. Saykin. (2014) Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion. PLoS ONE 9:5, pages e96713.
Crossref
Gaia Schiavon & Ian E Smith. (2014) Status of adjuvant endocrine therapy for breast cancer. Breast Cancer Research 16:2.
Crossref
Barbara Collins, Joyce MacKenzie, Giorgio A. Tasca, Carole Scherling & Andra Smith. (2013) Persistent Cognitive Changes in Breast Cancer Patients 1 Year Following Completion of Chemotherapy. Journal of the International Neuropsychological Society 20:4, pages 370-379.
Crossref
Jeanne S. Mandelblatt, Arti Hurria, Brenna C. McDonald, Andrew J. Saykin, Robert A. Stern, John W. VanMeter, Meghan McGuckin, Tiffani Traina, Neelima Denduluri, Scott Turner, Darlene Howard, Paul B. Jacobsen & Tim Ahles. (2013) Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?. Seminars in Oncology 40:6, pages 709-725.
Crossref
Catherine M. Bender & Bethany D. Thelen. (2013) Cancer and Cognitive Changes: The Complexity of the Problem. Seminars in Oncology Nursing 29:4, pages 232-237.
Crossref
P. J. de Raaf, C. de Klerk & C. C. D. van der Rijt. (2013) Elucidating the behavior of physical fatigue and mental fatigue in cancer patients: a review of the literature. Psycho-Oncology 22:9, pages 1919-1929.
Crossref
Marleen J. J. Pullens, Jolanda De Vries, Laurence J. C. Van Warmerdam, Marieke A. Van De Wal & Jan A. Roukema. (2012) Chemotherapy and cognitive complaints in women with breast cancer. Psycho-Oncology 22:8, pages 1783-1789.
Crossref
Barbara Collins, Joyce MacKenzie, Giorgio A. Tasca, Carole Scherling & Andra Smith. (2012) Cognitive effects of chemotherapy in breast cancer patients: a dose–response study. Psycho-Oncology 22:7, pages 1517-1527.
Crossref
Marie Østby-Deglum & Alv A. Dahl. (2013) Er cytostatika skadelig for hjernen?. Tidsskrift for Den norske legeforening 133:14, pages 1464-1465.
Crossref
Saadettin Kilickap, Mutlu Hayran, Banu Cakir, Nesrin Cilingiroglu, Mustafa Erman, Guldal Buyukdamgaci & Yavuz Ozisik. (2013) Effect of Endocrine Therapy on Quality of Life and Cognitive Functions in Patients with Breast Cancer. Breast Care 8:2, pages 128-132.
Crossref
Amanda D. Hutchinson, Jessica R. Hosking, Ganessan Kichenadasse, Julie K. Mattiske & Carlene Wilson. (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews 38:7, pages 926-934.
Crossref
Anneleen Lintermans, Olivier Brouckaert & Patrick Neven. (2012) Managing the side effects of oral aromatase inhibitors. Breast Cancer Management 1:2, pages 165-173.
Crossref
Elham Hedayati, Hassan Alinaghizadeh, Anna Schedin, Håkan Nyman & Maria Albertsson. (2012) Effects of adjuvant treatment on cognitive function in women with early breast cancer. European Journal of Oncology Nursing 16:3, pages 315-322.
Crossref
Jeffrey S. Wefel & Sanne B. Schagen. (2012) Chemotherapy-Related Cognitive Dysfunction. Current Neurology and Neuroscience Reports 12:3, pages 267-275.
Crossref
K Ribi, J Aldridge, K-A Phillips, A Thompson, V Harvey, B Thürlimann, F Cardoso, O Pagani, A S Coates, A Goldhirsch, K N Price, R D Gelber & J Bernhard. (2012) Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British Journal of Cancer 106:10, pages 1618-1625.
Crossref
Hiroyuki Takei, Shozo Ohsumi, Kojiro Shimozuma, Megumi Takehara, Kimito Suemasu, Yasuo Ohashi & Yasuo Hozumi. (2012) Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04). Breast Cancer Research and Treatment 133:1, pages 227-236.
Crossref
C. M. T. Schilder, C. Seynaeve, S. C. Linn, W. Boogerd, L. V. A. M. Beex, C. M. Gundy, J. W. R. Nortier, C. J. H. van de Velde, F. S. A. M. van Dam & S. B. Schagen. (2011) Self‐reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side‐study. Psycho-Oncology 21:5, pages 479-487.
Crossref
Ellen A. Walker, John J. Foley, Rachel Clark-Vetri & Robert B. Raffa. (2011) Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology 217:4, pages 539-548.
Crossref
Michiel B. de Ruiter, Liesbeth Reneman, Willem Boogerd, Dick J. Veltman, Frits S.A.M. van Dam, Aart J. Nederveen, Epie Boven & Sanne B. Schagen. (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping 32:8, pages 1206-1219.
Crossref
T. MITCHELL & P. TURTON. (2011) ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study. European Journal of Cancer Care 20:4, pages 539-548.
Crossref
Susan F. Dent, Rania Gaspo, Michelle Kissner & Kathleen I. Pritchard. (2011) Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Research and Treatment 126:2, pages 295-310.
Crossref
Kelly Anne Phillips, Karin Ribi & Richard Fisher. (2011) Do aromatase inhibitors have adverse effects on cognitive function?. Breast Cancer Research 13:1.
Crossref
Eun Hee ChoiBok Yae ChungGyung Duck KimKyung Hae KimHye Sun Byun. (2011) Literature Review of Cognitive Developmental Interventions on Patients with Breast Cancer undergoing Chemotherapy. Journal of Korean Oncology Nursing 11:1, pages 26.
Crossref
M.N.G. Dukes. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 851 880 .
Kerstin Hermelink, Helmut Küchenhoff, Michael Untch, Ingo Bauerfeind, Michael Patrick Lux, Markus Bühner, Juliane Manitz, Veronika Fensterer & Karin Münzel. (2010) Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psycho-Oncology 19:12, pages 1321-1328.
Crossref
Kunal Agrawal, Susan Onami, Joanne E. Mortimer & Sumanta Kumar Pal. (2010) Cognitive changes associated with endocrine therapy for breast cancer. Maturitas 67:3, pages 209-214.
Crossref
C.M.T. Schilder, C. Seynaeve, S.C. Linn, W. Boogerd, L.V.A.M. Beex, C.M. Gundy, J.W.R. Nortier, C.J.H. van de Velde, F.S.A.M. van Dam & S.B. Schagen. (2010) Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Critical Reviews in Oncology/Hematology 76:2, pages 133-141.
Crossref
Marleen J.J. Pullens, Jolanda De Vries & Jan A. Roukema. (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 19:11, pages 1127-1138.
Crossref
Jeanne Debess, Jens Østergaard Riis, Malene Cramer Engebjerg & Marianne Ewertz. (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Research and Treatment 121:1, pages 91-100.
Crossref
Christina M. Schilder, Caroline Seynaeve, Sabine C. Linn, Willem Boogerd, Chad M. Gundy, Louk V. Beex, Frits S. van Dam & Sanne B. Schagen. (2010) The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psycho-Oncology 19:4, pages 415-422.
Crossref
Christina M. SchilderCaroline SeynaeveLouk V. BeexWillem BoogerdSabine C. LinnChad M. GundyHilde M. HuizengaJohan W. NortierCornelis J. van de VeldeFrits S. van DamSanne B. Schagen. (2010) Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology 28:8, pages 1294-1300.
Crossref
Mary Sano, Diane Jacobs & Katya Gaynor. 2010. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine 142 148 .
Shelli R. Kesler, F. Chris Bennett, Misty L. Mahaffey & David Spiegel. (2009) Regional Brain Activation during Verbal Declarative Memory in Metastatic Breast Cancer. Clinical Cancer Research 15:21, pages 6665-6673.
Crossref
Andrea Vodermaier. (2009) Breast Cancer Treatment and Cognitive Function: The Current State of Evidence, Underlying Mechanisms and Potential Treatments. Women's Health 5:5, pages 503-516.
Crossref
Rowan Chlebowski, Jack Cuzick, Dereck Amakye, Ingo Bauerfeind, Aman Buzdar, Stephen Chia, Bruno Cutuli, Rick Linforth, Nicolaì Maass, Shinzaburo Noguchi, André Robidoux, Sunil Verma & Peyman Hadji. (2009) Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer. The Breast 18, pages S1-S11.
Crossref
Michael Feuerstein, Gina Luff, Mark Peugeot, Miki Moskowitz & Briana Todd. 2009. Foundations of Augmented Cognition. Neuroergonomics and Operational Neuroscience. Foundations of Augmented Cognition. Neuroergonomics and Operational Neuroscience 775 781 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.